Not Signed In -
Bupropion |
Wellbutrin |
Clinical Trial: Combinations of Pharmacologic Smoking Cessation Treatments
This study is no longer recruiting patients.
|
Purpose
The purpose of this study is to test the effectiveness of a combination of the drugs bupropion and mecamylamine along with a nicotine patch as a therapy for smoking cessation.
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Smoking | Drug: Bupropion Drug: Mecamylamine Drug: Nicotine Patch | Phase I |
MedlinePlus related topics: Smoking
Study Type: Interventional
Study Design: Treatment, Non-Randomized, Open Label, Uncontrolled, Single Group Assignment, Efficacy Study
Further Study Details:
Study start: November 1998; Study completion: June 2001
Eligibility
Ages Eligible for Study: 20 Years - 40 Years, Genders Eligible for Study: Both
Criteria
Subjects must be a smoker between 20 and 40 years old, have smoked at least 20 cigarettes per day for at least 2 years, wish to stop smoking and be in good general health
Location Information
California
VA Greater Los Angeles Healthcare System, Los Angeles, California, 90073, United States
Study chairs or principal investigators
Neil Hartman, M.D.
More Information
Study ID Numbers: ADRD-011-98S
Record last reviewed: November 2004
Last Updated: November 15, 2004
Record first received: July 3, 2001
ClinicalTrials.gov Identifier: NCT00018187
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Record last reviewed: November 2004
Last Updated: November 15, 2004
Record first received: July 3, 2001
ClinicalTrials.gov Identifier: NCT00018187
Health Authority: United States: Food and Drug Administration
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
